# The Potential of Carnosine Supplementation in Reducing the Cardiometabolic Risk

> **NCT02686996** · NA · UNKNOWN · sponsor: **Monash University** · enrollment: 84 (estimated)

## Conditions studied

- Insulin Sensitivity

## Interventions

- **DIETARY_SUPPLEMENT:** carnosine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02686996
- **Lead sponsor:** Monash University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-13
- **Primary completion:** 2020-02-13
- **Final completion:** 2020-06-12
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2018-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02686996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02686996, "The Potential of Carnosine Supplementation in Reducing the Cardiometabolic Risk". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02686996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*